Press Releases
McKesson Ventures’ Dave Schulte Named One of Healthcare’s Top 25 Investors
McKesson Ventures Managing Director Dave Schulte has been recognized by GrowthCap as one of the top 25 healthcare investors for 2023. This award acknowledges healthcare investors who have demonstrated high levels of sustained investment performance and who are recognized as leaders by portfolio company CEOs, industry...
Koneksa Announces Partnership with Beacon Biosignals for Clinical Trials in Sleep and Neurologic Disorders Using EEG Biomarkers
Koneksa has announced a partnership with Beacon Biosignals, a computational neurodiagnostics company, to launch a clinical trial to investigate the integration of Beacon’s at-home electroencephalogram (EEG) into the Koneksa Neuroscience Solution Toolkit. The Beacon platform unlocks longitudinal, at-home EEG...
Xealth Is Honored In 25th Anniversary Digital Health Awards®
McKesson Ventures portfolio company Xealth was selected as a winner in the 25th anniversary Digital Health Awards® program. This competition recognizes the best digital health resources. “Shaping Your Digital Health Future” received a Gold Award for Connected Digital Health: Consumer Directed Digital Health Programs....
RxLightning Closes $17.5M Series A to Accelerate Growth and Remove Barriers to Essential Specialty Medications
McKesson Ventures has participated in a $17.5 million Series A round for RxLightning, a platform for streamlining access and affordability for specialty medications. This brings the total the company has raised since its inception to $20.5 million. With RxLightning, healthcare providers—from those practicing at...
Aster Insights Announces that The University of Kansas Cancer Center will join the Oncology Research Information Network (ORIEN)
Aster Insights, a provider of technology-enabled data and analytics solutions for oncology discovery, has announced that The University of Kansas Cancer Center will join its Oncology Research Information Exchange Network (ORIEN). The KU Cancer Center is the latest NCI-designated cancer center to join ORIEN, which is...
ORIEN Member Presentations at 2023 ASCO Demonstrate Unique Value of Aster Insights’ Data
Aster Insights has announced its participation as a research partner at the American Society of Clinical Oncology (ASCO) Annual Meeting June 2-6, 2023, in Chicago. An oral presentation and three posters will be presented at this year’s ASCO meeting, utilizing the lifetime patient-consented longitudinal clinicogenomic...
Private AI and Replica Analytics announce partnership to tackle data privacy
Replica Analytics, an Aetion company, is partnering with data privacy software solutions developer Private AI. The partnership is a response to an urgent need for a privacy-preserving solution in healthcare and aims to provide a comprehensive solution for healthcare’s data privacy and security challenges. Replica...
Aster Insights Names Dr. Anand Shah as Chief Executive Officer
Aster Insights has announced the appointment of Dr. Anand Shah as chief executive officer, effective immediately. He succeeds Jim Gabriele, who has stepped down from his position. Gabriele and Shah have collaborated closely on a number of strategic, operational, and business development initiatives over the past six...
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
Twist Bioscience Corporation, a company that offers high-quality synthetic DNA using its silicon platform, along with Aster Insights, has announced the availability of the AsterExome panel, which can simultaneously enable whole exome sequencing (WES) with additional coverage for target regions known to contain 620...
Clinical ink Announces New Continuous Glucose Monitoring Solution
Clinical Ink, a global life science technology company, now offers continuous glucose monitoring (CGM) within its integrated digital biomarker solution. The new modules enable remote collection, central storage, and analysis of sensor data from commercially available devices for use in diabetes clinical trials. The...
Other News
Lessons from Farzad Mostashari, CEO and Co-Founder of Aledade, on Empowering Independent Primary & Value-Based Care
Aledade CEO and Co-Founder Farzad Mostashari was recently a guest on the Pear Healthcare Playbook podcast. In the talk, Mostashari discusses his journey to healthcare, how he started Aledade, the importance of independent physicians in value-based care, and how...
Real-Time Clinical Trial Monitoring at Clinical ink
Clinical Ink Senior Director Enterprise Architecture Alex Doan recently wrote a case study about how the company chose to use the Rockset analytics platform to improve query speed and other performance metrics. He began by explaining Clinical Ink, which he described...
McKesson Ventures’ Carrie Williams Speaks at 2023 DHIS Conference
McKesson Ventures Vice President & Partner Carrie Williams spoke at the Digital Healthcare Innovation Summit, East Coast, which took place June 6 and 7, 2023, in Boston. Williams participated in a panel discussion titled “Beyond the Clinic: Digital &...
RxLightning Closes $17.5M Series A to Accelerate Growth and Remove Barriers to Essential Specialty Medications
McKesson Ventures has participated in a $17.5 million Series A round for RxLightning, a platform for streamlining access and affordability for specialty medications. This brings the total the company has raised since its inception to $20.5 million. With RxLightning,...
Inbound Health launches at-home post-surgery care
Inbound Health, a company that enables health systems and health plans to offer hospital-at-home and skilled-nursing-at-home programs, has announced that it is expanding its services to include general surgery, including orthopedics, bariatrics, and hernia. Inbound...